Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teus van Laar

Showing results (21-30 of 155) with videos related to

Pageof 16
Sort By:
Practical Neurology|May 10, 2011
The treatment of early Parkinson's disease: levodopa rehabilitatedAnnemarie Vlaar, Ad Hovestadt, Teus van Laar, et al.
Parkinsonism & Related Disorders|July 4, 2021
Treatment of subcutaneous nodules after infusion of apomorphine; a biopsy-controlled study comparing 4 frequently used therapiesRobbert W K Borgemeester, Gilles F H Diercks, Teus van Laar
Contact Dermatitis|August 21, 2018
Cutaneous adverse drug reaction after apomorphine infusion, possibly caused by a systemic type IV hypersensitivity reaction to sodium metabisulfite: Report of 2 casesRobbert W K Borgemeester, Teus van Laar, Marie L A Schuttelaar
Scientific Reports|June 4, 2021
Electrical stimulation of the nucleus basalis of meynert: a systematic review of preclinical and clinical dataMuhammad Nazmuddin, Ingrid H C H M Philippens, Teus van Laar
BMJ Case Reports|June 29, 2018
Successful treatment of intractable visual hallucinations with 5-HT <sub></sub> antagonist ketanserinIris E C Sommer, Hidde Kleijer, Lucy Visser, et al.
Clinical Neuropharmacology|August 12, 2009
The effects of apomorphine on visual perception in patients with Parkinson disease and visual hallucinations: a pilot studyLinda Geerligs, Anne Marthe Meppelink, Wiebo H Brouwer, et al.
Clinical Neurology and Neurosurgery|August 25, 2009
Characteristics of dystonia in the 18p deletion syndrome, including a new caseAnna G Postma, Corien C Verschuuren-Bemelmans, Klaas Kok, et al.
CNS Spectrums|May 28, 2008
Managing Parkinson's disease with continuous dopaminergic stimulationErik Wolters, Andrew J Lees, Jens Volkmann, et al.
Archives of Physical Medicine and Rehabilitation|June 4, 2014
Clinical relevance of pharmacological and physiological data in intrathecal baclofen therapyHerre W Heetla, Michiel J Staal, Johannes H Proost, et al.
Movement Disorders Clinical Practice|December 14, 2023
Patient Referral for Device-Aided Therapies in Parkinson's Disease is Suboptimal; A Dutch SurveyHarmen R Moes, Jolien M Ten Kate, Erik Buskens, et al.
Pageof 16

Showing results (21-30 of 155) with videos related to

Sort By:
Pageof 16
Practical Neurology|May 10, 2011
The treatment of early Parkinson's disease: levodopa rehabilitatedAnnemarie Vlaar, Ad Hovestadt, Teus van Laar, et al.
Parkinsonism & Related Disorders|July 4, 2021
Treatment of subcutaneous nodules after infusion of apomorphine; a biopsy-controlled study comparing 4 frequently used therapiesRobbert W K Borgemeester, Gilles F H Diercks, Teus van Laar
Contact Dermatitis|August 21, 2018
Cutaneous adverse drug reaction after apomorphine infusion, possibly caused by a systemic type IV hypersensitivity reaction to sodium metabisulfite: Report of 2 casesRobbert W K Borgemeester, Teus van Laar, Marie L A Schuttelaar
Scientific Reports|June 4, 2021
Electrical stimulation of the nucleus basalis of meynert: a systematic review of preclinical and clinical dataMuhammad Nazmuddin, Ingrid H C H M Philippens, Teus van Laar
BMJ Case Reports|June 29, 2018
Successful treatment of intractable visual hallucinations with 5-HT <sub></sub> antagonist ketanserinIris E C Sommer, Hidde Kleijer, Lucy Visser, et al.
Clinical Neuropharmacology|August 12, 2009
The effects of apomorphine on visual perception in patients with Parkinson disease and visual hallucinations: a pilot studyLinda Geerligs, Anne Marthe Meppelink, Wiebo H Brouwer, et al.
Clinical Neurology and Neurosurgery|August 25, 2009
Characteristics of dystonia in the 18p deletion syndrome, including a new caseAnna G Postma, Corien C Verschuuren-Bemelmans, Klaas Kok, et al.
CNS Spectrums|May 28, 2008
Managing Parkinson's disease with continuous dopaminergic stimulationErik Wolters, Andrew J Lees, Jens Volkmann, et al.
Archives of Physical Medicine and Rehabilitation|June 4, 2014
Clinical relevance of pharmacological and physiological data in intrathecal baclofen therapyHerre W Heetla, Michiel J Staal, Johannes H Proost, et al.
Movement Disorders Clinical Practice|December 14, 2023
Patient Referral for Device-Aided Therapies in Parkinson's Disease is Suboptimal; A Dutch SurveyHarmen R Moes, Jolien M Ten Kate, Erik Buskens, et al.
Pageof 16